metricas
covid
Buscar en
Gastroenterología y Hepatología (English Edition)
Toda la web
Inicio Gastroenterología y Hepatología (English Edition) Hepatic and splenic sarcoidosis as multiple micro-nodular formations
Información de la revista
Vol. 43. Núm. 2.
Páginas 95-96 (febrero 2020)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Visitas
728
Vol. 43. Núm. 2.
Páginas 95-96 (febrero 2020)
Image of the month
Acceso a texto completo
Hepatic and splenic sarcoidosis as multiple micro-nodular formations
Sarcoidosis hepato-esplénica con patrón micronodular
Visitas
728
Umberto G. Rossia,
Autor para correspondencia
, Mariangela Rutiglianib, Giancarlo Antonuccic, Gian Andrea Rollandid
a Department of Radiological Area – Interventional Radiology Unit, E.O. Galliera Hospital, Mura delle Cappuccine, 14, 16128 Genova, Italy
b Department of Laboratory and Service – Histological and Anatomical Pathology Unit, E.O. Galliera Hospital, Mura delle Cappuccine, 14, 16128 Genova, Italy
c Department of Medicine Area – Internal Medicine Unit, E.O. Galliera Hospital, Mura delle Cappuccine, 14, 16128 Genova, Italy
d Department of Radiological Area – Radiology Unit, E.O. Galliera Hospital, Mura delle Cappuccine, 14, 16128 Genova, Italy
Este artículo ha recibido
Información del artículo
Texto completo
Bibliografía
Descargar PDF
Estadísticas
Figuras (3)
Mostrar másMostrar menos
Texto completo

A 48-year-old woman arrived in our emergency department for acute upper abdominal pain with nausea. At the time of her presentation haematological examinations were within the normal limits, with just a minimum increase of reactive C protein (0.82mg/dl). There was no alteration in liver function tests. Abdominal contrast-enhanced multi-detector computed tomography (MD-CT) revealed a heterogeneous structure of the liver and of the spleen with multiple micro-nodular formations and the presence of hepatic hilar lymph nodes (Fig. 1). These hepatic and splenic multiple micro-nodular formations and the hilar lymph nodes resulted PET/CT scan positive (Fig. 2); no thoracic signs were noted. Patient then performed serological (hepatitis, echinococcus, toxocara canis, leishmania) and parasitic (protozoa, helminths, and ectoparasites) tests, both types of tests resulted negative. ACE level was in normal range.

Figure 1.

Axial MultiDetector Computed Tomography that shows the presence of hepatic and splenic multiple micro-nodular formations.

(0.09MB).
Figure 2.

Axial PET/CT scan that confirms the increased SUV at liver and splenic level.

(0.06MB).

After multidisciplinary discussion, patient underwent ultrasound guided liver core needle biopsy. Hepatic histopathological evaluation demonstrated granuloma formations, T-lymphocytes, multinucleated giant cells, fibrosis and no malignant cells (Fig. 3). These data allowed us to make the diagnosis of sarcoidosis. Patient underwent medical treatment with corticosteroid and neither recurrence of hepatic and splenic sarcoidosis was noted at 9 months.

Figure 3.

Histopathological evaluation that shows granuloma formations, T-lymphocytes, multinucleated giant cells and fibrosis.

(0.25MB).

Sarcoidosis is a systemic granulomatous disease. Pulmonary findings are the most common site of disease activity.1 It is rare extra-pulmonary disease as initial findings in sarcoidosis, especially in hepatic and splenic parenchyma.2,3 Imaging studies showed hepatic and splenic parenchymal heterogeneous structure changes due to granuloma formations, which must be differentiated from possible inflammatory or infectious or tumour processes.2–5 These granuloma formations, like most metabolically active processes, are CT/PET positive. Laboratory markers are nonspecific. But in 65% of patients’ ACE level are elevated and in ¼ of patients liver function test are derangements.2,6 Ultrasound guided core needle biopsy remains the minimally invasive manoeuvre for the certain differential diagnosis.7,8 Not all cases of hepatic and splenic sarcoidosis require treatment. But, symptomatic patients need it, and first line treatment includes corticosteroids or ursodeoxycholic acid.9

Funding

The authors declare that there is no financing plan.

Author's contribution

Umberto G. Rossi, MD, EBIR: write paper, diagnosis, images.

Mariangela Rutigliani: review paper, diagnosis, image.

Giancarlo Antonucci: review paper, diagnosis, treatment.

Gian Andrea Rollandi: contribution to write paper, diagnosis, images.

Conflict of interest

The authors declare that there is no conflict of interest.

References
[1]
S. Nagai, T. Handa, Y. Ito, K. Ohta, M. Tamaya, T. Izumi.
Outcome of sarcoidosis.
Clin Chest Med, 29 (2008), pp. 565-574
[2]
D.T. Fetzer, M.A. Rees, A.K. Dasyam, M.E. Tublin.
Hepatic sarcoidosis in patients presenting with liver dysfunction: imaging appearance, pathological correlation and disease evolution.
Eur Radiol, 26 (2016), pp. 3129-3137
[3]
Y. Yonenaga, F. Kushihata, H. Inoue, J. Watanabe, T. Tohyama, A. Sugita, et al.
Sarcoidosis manifesting as hepatic and splenic nodules mimicking ovarian cancer metastases: a case report.
Oncol Lett, 10 (2015), pp. 2166-2170
[4]
A. Barberis, U.G. Rossi, M. Filauro.
Cholangitis mimicking hilar cholangiocarcinoma.
Rev Gastroenterol Mex, 84 (2019), pp. 245-247
[5]
U.G. Rossi, G. Rubis Passoni, M. Cariati.
Hydatid cyst of the liver.
Rev Gastroenterol Mex, 81 (2016), pp. 105-106
[6]
T. Abdallah, M. Abdallah, D. Elsayegh, M. Chalhoub, G. Khoueiry, A. Glatman, et al.
Isolated dysphagia unmasking bulbar neurosarcoidosis and pulmonary sarcoidosis.
Arab J Gastroenterol, 15 (2014), pp. 85-87
[7]
M. Tadros, F. Forouhar, G.Y. Wu.
Hepatic sarcoidosis.
J Clin Transl Hepatol, 1 (2013), pp. 87-93
[8]
S. Rizvi, K. Clarke, M. Schwartz, M.I. Saul, L. Baidoo.
Gastrointestinal and hepatic involvement in sarcoidosis: a biopsy proven cohort.
Gastroenterology, 140 (2011), pp. S-727
[9]
S. Deutsch-Link, D. Fortuna, E.M. Weinberg.
A comprehensive review of hepatic sarcoid.
Semin Liver Dis, 38 (2018), pp. 284-297
Descargar PDF
Opciones de artículo
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos

Quizás le interese:
10.1016/j.gastre.2020.03.014
No mostrar más